Filtered By:
Condition: Asthma
Vaccination: Vaccines
This page shows you your search results in order of date.
Order by Relevance | Date
Total 883 results found since Jan 2013.
Chronic Respiratory Diseases as a Risk Factor for Herpes Zoster Infection
CONCLUSIONS: In a standard clinical practice setting, the most prevalent respiratory diseases (asthma, COPD and lung cancer) are related to a higher risk of HZ and PHN. These data are fundamental to assess the potential impact of vaccination in this population.PMID:37734964 | DOI:10.1016/j.arbres.2023.08.010
Source: Archivos de Bronconeumologia - September 21, 2023 Category: Respiratory Medicine Authors: Diego Morena Sara Lumbreras Jos é Miguel Rodríguez Carolina Campos Mar ía Castillo Mar ía Benavent Jos é Luis Izquierdo Source Type: research
Comprehensive care of adults with respiratory diseases must include vaccines
Ann Allergy Asthma Immunol. 2023 Sep;131(3):292-293. doi: 10.1016/j.anai.2023.05.023.NO ABSTRACTPMID:37661170 | DOI:10.1016/j.anai.2023.05.023
Source: Annals of Allergy, Asthma and Immunology - September 3, 2023 Category: Allergy & Immunology Authors: Barbara P Yawn Dennis Williams Gregory Poland Source Type: research
A qualitative investigation into vaccine hesitancy and confidence amongst people managing allergy
Ann Allergy Asthma Immunol. 2023 Aug 29:S1081-1206(23)01208-5. doi: 10.1016/j.anai.2023.08.600. Online ahead of print.NO ABSTRACTPMID:37652234 | DOI:10.1016/j.anai.2023.08.600
Source: Annals of Allergy, Asthma and Immunology - August 31, 2023 Category: Allergy & Immunology Authors: Ayel Luis R Batac Kaitlyn A Merrill Michael A Golding Elissa M Abrams Philippe B égin Moshe Ben-Shoshan Erika Ladouceur Leslie E Roos Vladan Protudjer Jennifer L P Protudjer Source Type: research
Vaccine-elicited B and T cell immunity to SARS-CoV-2 is impaired in chronic lung disease patients
CONCLUSIONS: Deep immune phenotyping of the SARS-CoV-2 vaccine response revealed the complex nature of vaccine-elicited immunity and highlights the need for more personalised vaccination schemes in patients with underlying lung conditions.PMID:37583809 | PMC:PMC10423317 | DOI:10.1183/23120541.00400-2023
Source: Cell Research - August 16, 2023 Category: Cytology Authors: Haolin Liu Katja Aviszus Pearlanne Zelarney Shu-Yi Liao Anthony N Gerber Barry Make Michael E Wechsler Philippa Marrack R Lee Reinhardt Source Type: research
Serum Level of Antibodies Against Novel Acinetobacter Baumannii OmpA-selected Peptides in ICU Staff: Promise for the Future of Vaccine Development
This study demonstrates A baumannii colonization at human mucosal surfaces, especially in exposed healthy workers. Novel OmpA-derived peptides could be used to identify immunogenic vaccine candidates. Therefore, more studies are needed before this peptide and antibody levels are used in diagnosis, prevention, or treatment.PMID:37496408 | DOI:10.18502/ijaai.v22i2.12676
Source: Iranian Journal of Allergy, Asthma and Immunology - July 27, 2023 Category: Allergy & Immunology Authors: Shadi Paydarfar Mohammad Amin Abbasi Ali Hashemi Sodabe Taheri Mojgan Bandehpour Nariman Mosaffa Source Type: research
Oral Nirmatrelvir and Ritonavir for Covid-19 in Vaccinated, Non-Hospitalized Adults, Ages 18-50 Years
CONCLUSION: NMV-r use in vaccinated adults aged 18-50, especially with serious comorbidities, was associated with reduced all-cause hospital visits, hospitalization, and mortality in the first 30 days of Covid-19 illness. However, NMR-r in patients without significant comorbidities or with only asthma/COPD had no association of benefit. Therefore, identifying high-risk patients should be a priority and avoid over-prescription should be avoided.PMID:37387690 | DOI:10.1093/cid/ciad400
Source: Cancer Control - June 30, 2023 Category: Cancer & Oncology Authors: Jeremy Samuel Faust Ashish Kumar Jui Shah Sumanth Khadke Sourbha S Dani Sarju Ganatra Paul E Sax Source Type: research
Epidemiological study of vaccination against SARS-CoV-2 and its impact on COVID-19 progression in a cohort of patients in gran Canaria
Conclusions. Cancer, coronary heart disease, and immunosuppressive treatment were associated with increased COVID-19 mortality. More complete vaccination was associated with lower risk of hospital admission or death. Three doses of the SARS-CoV-2 vaccine were highly associated with the prevention of death and hospital admission in all age groups. These findings suggest that COVID-19 vaccination can help bring the pandemic under control.PMID:37366493 | PMC:PMC10288311 | DOI:10.1016/j.vacun.2023.06.005
Source: Cancer Control - June 27, 2023 Category: Cancer & Oncology Authors: Alejandro de Arriba Fern ández Jos é Luis Alonso Bilbao Alberto Espi ñeira Francés Antonio Cabeza Mora Ángela Gutiérrez Pérez Miguel Ángel Díaz Barreiros Source Type: research
Necrotizing pancreatitis, microangiopathic hemolytic anemia and thrombocytopenia following the second dose of Pfizer/BioNTech COVID-19 mRNA vaccine
We report a 31-year-old female with a history of borderline personality disorder, intravenous drug abuse, allergic asthma, eating disorder, psoriatic arthritis treated with tofacitinib, neurogenic bladder disturbance, cholecystectomy, recurrent thoracic herpes zoster, vaginal candida infections and urinary tract infections, who developed pancreatitis associated with thrombotic microangiopathy and hemolytic-uremic syndrome 10 days after the second vaccination, whereas the first has been well tolerated. She was treated by plasma exchange, and eventually by transgastric drainage with implantation of a plastic stent to remove ...
Source: Herpes - June 6, 2023 Category: Infectious Diseases Authors: Claudia St öllberger Kastriot Kastrati Clemens Dejaco Martina Scharitzer Josef Finsterer Patrick Bugingo Madeleine Melichart-Kotik Astrid Wilfing Source Type: research
